Combinations of alkaloids affecting different molecular targets with the saponin digitonin can synergistically enhance trypanocidal activity against Trypanosoma brucei brucei.
The flagellate Trypanosoma brucei causes sleeping sickness in humans and nagana in animals. Only a few drugs are registered to treat trypanosomiasis, but those drugs show severe side effects. Also, because some pathogen strains have become resistant, new strategies are urgently needed to combat this parasitic disease. An underexplored possibility is the application of combinations of several trypanocidal agents, which may potentiate their trypanocidal activity in a synergistic fashion. In this study, the potential synergism of mutual combinations of bioactive alkaloids and alkaloids with a membrane-active steroidal saponin, digitonin, was explored with regard to their effect on T. b. brucei. Alkaloids were selected that affect different molecular targets: berberine and chelerythrine (intercalation of DNA), piperine (induction of apoptosis), vinblastine (inhibition of microtubule assembly), emetine (intercalation of DNA, inhibition of protein biosynthesis), homoharringtonine (inhibition of protein biosynthesis), and digitonin (membrane permeabilization and uptake facilitation of polar compounds). Most combinations resulted in an enhanced trypanocidal effect. The addition of digitonin significantly stimulated the activity of almost all alkaloids against trypanosomes. The strongest effect was measured in a combination of digitonin with vinblastine. The highest dose reduction indexes (DRI) were measured in the two-drug combination of digitonin or piperine with vinblastine, where the dose of vinblastine could be reduced 9.07-fold or 7.05-fold, respectively. The synergistic effects of mutual combinations of alkaloids and of alkaloids with digitonin present a new avenue to treat trypanosomiasis but one which needs to be corroborated in future animal experiments.
Institute of Pharmacy and Molecular Biotechnology, Heidelberg University, Heidelberg, Germany krstin@uni-heidelberg.de wink@uni-hd.de.
Sonja
S
Krstin
Institute of Pharmacy and Molecular Biotechnology, Heidelberg University, Heidelberg, Germany.
Herbenya Silva
HS
Peixoto
Institute of Pharmacy and Molecular Biotechnology, Heidelberg University, Heidelberg, Germany krstin@uni-heidelberg.de wink@uni-hd.de.
Michael
M
Wink
D000470:Alkaloids / Q000494:pharmacology*; D000818:Animals; D052117:Benzodioxoles / Q000494:pharmacology; D053119:Benzophenanthridines / Q000494:pharmacology; D001599:Berberine / Q000494:pharmacology; D004072:Digitonin / Q000494:pharmacology; D004338:Drug Combinations; D004357:Drug Synergism; D004640:Emetine / Q000494:pharmacology; D006248:Harringtonines / Q000494:pharmacology; D000077863:Homoharringtonine; D008962:Models, Theoretical; D010880:Piperidines / Q000494:pharmacology; D053284:Polyunsaturated Alkamides / Q000494:pharmacology; D014344:Trypanocidal Agents / Q000494:pharmacology*; D014346:Trypanosoma brucei brucei / Q000187:drug effects*; D014747:Vinblastine / Q000494:pharmacology
D000470:Alkaloids; D052117:Benzodioxoles; D053119:Benzophenanthridines; D004338:Drug Combinations; D006248:Harringtonines; D010880:Piperidines; D053284:Polyunsaturated Alkamides; D014344:Trypanocidal Agents; D001599:Berberine; D014747:Vinblastine; D000077863:Homoharringtonine; C016299:chelerythrine; D004072:Digitonin; C008922:piperine; D004640:Emetine